A review of treatment guidelines published in Psychotherapy and Psychosomatics found that guidelines “shy away from stating clearly that SSRIs/SNRIs, like BDZs, are often (though not always) associated with pharmacological dependence, which is manifested through the withdrawal symptoms during their discontinuation.”
Support MIA
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.